HIGHFDA DRUG
Trifecta Pharmaceuticals Recalls Zinc Oxide Ointment Due to cGMP Deviations
Trifecta Pharmaceuticals recalled 33,000 containers of Globe Zinc Oxide Ointment on October 31, 2025, due to cGMP deviations. Consumers should stop using the product immediately to avoid potential risks. Healthcare providers are advised to contact the company for further guidance.
ZINC OXIDE 20%
cGMP deviations